download - Malaysian Thoracic Society

More documents

Recommendations

Info

Annual Congress of Malaysian Thoracic Society Symposium 3A COPD Roles of Unconventional Therapy in Stable COPD Michael Joseph Malaysia COPD is a disease caused by inflammation triggered by noxious stimuli, primarily cigarette smoke in most cases. The inflammation is both local (pulmonary) & systemic, accounting for most of COPD’s manifestations. Therapies for COPD thus far (conventional or guideline-defined) have been proven in numerous large randomised trials to have benefits in improving symptoms & quality of life, preventing exacerbations & reducing mortality. However, despite these benefits, they still fall short in their ability to prevent progression of the disease. This is presumably due to incomplete resolution of the underlying inflammatory process. Thus, the search continues for the ultimate COPD therapy. In the process, several drugs have been found to have potential beneficial effects in COPD & may play a role in the future management of the disease. Robust evidence for these (unconventional) therapies is lacking though. The lecture will look at several of these therapies – statins, beta blockers, macrolide antibiotics & mucolytics- & discuss their potential roles in COPD management. Symposium 3A COPD Treatment beyond inhalers: Lung volume reduction surgery Anand Sachithanandan Malaysia Patients with end stage advanced emphysema have a poor quality of life and reduced survival. Historically, the only treatment has been pulmonary rehabilitation with medical therapy. Lung volume reduction surgery (LVRS) and lung transplantation are the two main surgical options potentially available to such patients. This lecture is a comprehensive overview of LVRS. The historical origin and evolution of the procedure, the rationale and principle of LVRS, indications for surgery, patient selection criteria, the evidence for LVRS, technical surgical considerations and early/midterm surgical outcomes including results from the seminal North American NETT trial will be discussed. 27
Annual Congress of Malaysian Thoracic Society Symposium 3B Interventional Pulmonology Interventional Pulmonology in Malaysia – a Respiratory Physician’s Perspective Jamalul Azizi Malaysia Interventional pulmonology (IP) is an emerging field within pulmonary medicine with focus on minimally invasive techniques for the diagnosis and management of lung cancer, central airway obstruction and pleural disease. The first National IP course in 2007, at Kota Kinabalu, Sabah had ushered in a new era in Malaysia. In the past, the role of respiratory physicians in Malaysia was confined to managing tuberculosis, asthma, COAD and diagnosing lung cancer. Procedures were limited to flexible bronchoscopy and closed blind pleural biopsy. Determined to change the landscape of respiratory medicine in Malaysia, a group of brave respiratory physicians and a cardio-thoracic surgeon pioneered a National IP course 4 years ago in Sabah. This course consisted of didactic lectures, live cases and hands-on workshop. Encouraged by the positive response, the second course was held in Kuantan, Pahang in 2008. The third course returned to Kota Kinabalu, Sabah in 2009 which was also attended by international participants. This year, the course will be held at Kota Kinabalu again 5-7 October. Currently, there are three IP centres in Malaysia namely Queen Elizabeth Hospital, Kota Kinabalu, Sabah, International Islamic University, Kuantan, Pahang and Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur. IP encompasses interventional bronchoscopy and pleuroscopy. These can be either for diagnostic or therapeutic purposes. Certain bronchoscopic procedures need to be performed via rigid bronchoscopy especially when bleeding is a potential threat. As more respiratory physicians take up pleuroscopy, closed blind pleural biopsy may eventually become obsolete. In the near future, it is hoped that there will be local and international collaborations in this fast growing field. The centre in Sabah has already received an invitation from an American centre to collaborate in this field. A Special Interest Group (SIG) on IP has been formed in Malaysia. The most important relationship for IP is that with thoracic surgery. These two specialties commonly share patients with clinical quandary. Interventional pulmonologists need the surgical back-up of the thoracic surgeon and the access to advanced surgical interventions for their patients. Similarly, the thoracic surgeons benefit from the availability of an advanced bronchoscopist and dedicated clinician with appropriate referrals for surgical resection. We hope to leave behind a legacy for the next generation to take over and bring Malaysian IP to greater heights. 28
Page 2 and 3: anniversary MALAYSIAN THORACIC SOCI
Page 4 and 5: AnnuAl Congress of MAlAysiAysi An T
Page 8 and 9: anniversary MALAYSIAN THORACIC SOCI
Page 18 and 19: Annual Congress of Malaysian Thorac
Page 78 and 79:
Annual Congress of Malaysian Thorac
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
show all

download - Malaysian Thoracic Society

Create successful ePaper yourself

Delete template?

Save as template?